Neuroendocrine Cancer clinical trials at UCLA

1 research study open to eligible people

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
open to eligible people ages 18 years and up
The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
Los Angeles, California and other locations

Our lead scientists for Neuroendocrine Cancer research studies include Joel Hecht, MD.

Last updated: October 29, 2026

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors